Paroxetine (Pari CR (25 mg)) is an SSRI antidepressant, prescribed for major depression, obsessive-compulsive disorder, panic disorder, social anxiety and generalized anxiety disorder.It increases the ...

Lannett Company, Inc. (NYSE: LCI) revealed it received FDA approval recently for its Abbreviated New Drug Application (ANDA) for Paroxetine Extended Release Tablets USP, 12.5 mg, 25 mg and 37.5 mg.

July 13, 2007 — The US Food and Drug Administration (FDA) has approved first-time generic formulations for paroxetine hydrochloride extended release tablets, 12.5 mg and 25 mg, for the treatment of ...

Angel Tax Wipro Budget news New Income tax slab IPO News Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting ...

A pharmaceutical product that has tentative approval cannot be marketed or sold in the US. Photo: Bloomberg New Delhi: Lupin Ltd, the country’s Mumbai-based third largest drug maker, said on Friday ...

NEW YORK (Reuters) - Mylan Inc said on Wednesday it had launched generic versions of GlaxoSmithKline PLC's Paxil CR antidepressant, and its shares rose 2.6 percent. Last October, Mylan announced a ...

One month later, a U.S. District Court denied a motion for a preliminary injunction filed by Mylan to prevent Apotex from making a generic version of the antidepressant drug. “The language plainly ...

GlaxoSmithKline has returned its antidepressant Paxil CR to the market, nearly four months after federal officials seized the drug from three factories for failing to meet manufacturing standards. The ...

There are many challenges in the pharmacologic management of elderly patients with anxiety disorders, including an increased sensitivity to drug effects, reduced drug metabolism, and socioeconomic ...